Status:
COMPLETED
Effectiveness of Prolonged Use of IUD/Implant for Contraception
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Susan Thompson Buffett Foundation
Conditions:
Contraception
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to ...
Detailed Description
This prospective cohort study will evaluate 675 LNG-IUD users and 675 Etonogestrel (ENG) Implant users who are within 6 months of expiration or beyond the end of the FDA-approved duration. Participant...
Eligibility Criteria
Inclusion
- Women age 18-45
- Within 6 months of expiration or beyond the end of the FDA-approved duration of use of the levonorgestrel intrauterine device (LNG-IUD = 5 years) OR the etonogestrel-releasing subdermal implant (ENG implant = 3 years)
- Able to consent in English or Spanish.
- Not pregnant at the time of enrollment
Exclusion
- Have history of female sterilization procedure
- Desire for conception in the next 12 months
- Not sexually active with a male partner
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
1076 Patients enrolled
Trial Details
Trial ID
NCT02267616
Start Date
December 1 2011
End Date
March 31 2021
Last Update
April 15 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202
2
Washington University in St. Louis School of Medicine
St Louis, Missouri, United States, 63110